Literature DB >> 11680671

Botulinophilia: contraindication for therapy with botulinum toxin.

W Harth1, R Linse.   

Abstract

Botulinum toxin inhibits neuromuscular transmission and is one of the most potent toxins. It has proven to be effective in the treatment of hyperhidrosis and is being more frequently demanded for therapy. Patients with body dysmorphic disorder also seek costly treatment with botulinum toxin. This botulinophilia is a new venenophilia. Body dysmorphic disorder is defined as a preoccupation with an imagined defect in appearance. If a slight physical anomaly is present, the person's concern is markedly exessive. The patient's preoccupation causes clinically significant distress or impairment in socially, occupational, or other important areas of functioning. The sweat test according to Minor is negative. Patients with botulinophilia are among the most difficult patients managed by the dermatologist. They are demanding and time-consuming. In our clinic, 23.1% of a series of patients seeking treatment with botulinum toxin screened positive for body dysmorphic disorder. Botulinophilia is a contraindication for therapy with botulinum toxin but is an indication for psychotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680671

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  7 in total

1.  The changed image of botulinum toxin.

Authors:  V Peter Misra
Journal:  BMJ       Date:  2002-11-23

Review 2.  [Nihilodermia in psychodermatology].

Authors:  W Harth; B Hermes; K Seikowski; U Gieler
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 3.  [Lifestyle diseases in dermatology].

Authors:  W Harth; A Hillert
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

4.  [Botulinum toxin: the misguided path].

Authors:  W Harth
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

5.  Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder.

Authors:  Canice E Crerand; William Menard; Katharine A Phillips
Journal:  Ann Plast Surg       Date:  2010-07       Impact factor: 1.539

6.  Delusional hyperhidrosis: A case report and recommendations for management.

Authors:  Megan V Ha; Sherry H Yu
Journal:  JAAD Case Rep       Date:  2022-09-22

Review 7.  [Lifestyle drugs in medicine].

Authors:  Wolfgang Harth; Kurt Seikowski; Barbara Hermes; Uwe Gieler
Journal:  Wien Med Wochenschr       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.